1. Home
  2. LOCO vs REPL Comparison

LOCO vs REPL Comparison

Compare LOCO & REPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo El Pollo Loco Holdings Inc.

LOCO

El Pollo Loco Holdings Inc.

HOLD

Current Price

$13.81

Market Cap

411.3M

ML Signal

HOLD

Logo Replimune Group Inc.

REPL

Replimune Group Inc.

HOLD

Current Price

$9.50

Market Cap

407.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LOCO
REPL
Founded
1980
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
411.3M
407.1M
IPO Year
2014
2018

Fundamental Metrics

Financial Performance
Metric
LOCO
REPL
Price
$13.81
$9.50
Analyst Decision
Buy
Hold
Analyst Count
4
9
Target Price
$14.17
$5.67
AVG Volume (30 Days)
357.3K
8.0M
Earning Date
05-07-2026
05-21-2026
Dividend Yield
N/A
N/A
EPS Growth
4.65
5.25
EPS
0.27
N/A
Revenue
$401,701,000.00
N/A
Revenue This Year
$3.60
N/A
Revenue Next Year
$3.98
N/A
P/E Ratio
$51.26
N/A
Revenue Growth
5.68
N/A
52 Week Low
$8.99
$1.50
52 Week High
$15.90
$13.24

Technical Indicators

Market Signals
Indicator
LOCO
REPL
Relative Strength Index (RSI) 48.96 73.26
Support Level $13.52 $6.81
Resistance Level $14.38 $10.67
Average True Range (ATR) 0.49 0.75
MACD -0.03 0.53
Stochastic Oscillator 19.18 77.54

Price Performance

Historical Comparison
LOCO
REPL

About LOCO El Pollo Loco Holdings Inc.

El Pollo Loco Holdings Inc operates and franchises hundreds of fast-casual chicken restaurants in the United States. It specializes in fire-grilling citrus-marinated chicken and operates in the limited service restaurant market segment. Its offerings include Mexican-inspired menu items, including burritos, tostadas, bowls, salads, and bone-in chicken meals in various portion sizes. It also offers citrus-marinated fire-grilled chicken, along with a range of salsas and dressings that allow customers to customize their meals. The company operates in one operating segment. The majority of the company's revenue is derived from company-operated restaurant revenue.

About REPL Replimune Group Inc.

Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.

Share on Social Networks: